HealthEdge
Acquisition in 2025
HealthEdge is a technology company that provides an integrated software platform designed for healthcare payors. Founded in December 2004 by Albert Waxman and Rob Gillette, HealthEdge specializes in delivering innovative solutions that help health insurers enhance operational efficiency, improve patient outcomes, and significantly lower administrative costs. The company's flagship product suite, HealthRules, is built on patented technology and can be deployed via the HealthEdge Cloud or on-premises. This platform encompasses various functionalities, including claims and benefits administration, care management, and business intelligence, enabling clients to adopt new business models and streamline processes within the healthcare delivery system. In 2012, HealthEdge expanded its offerings by acquiring Click4Care, which enhanced its capabilities in clinical care management. Headquartered in Burlington, Massachusetts, HealthEdge also has a research and development center in Powell, Ohio.
Mitsubishi Tanabe Pharma
Acquisition in 2025
Mitsubishi Tanabe Pharma Corporation is a pharmaceutical company headquartered in Osaka, Japan, that manufactures and sells a diverse range of drugs across Japan, Europe, North America, and other Asian countries. The company focuses on developing treatments for various medical conditions, including immuno-inflammation, diabetes, kidney diseases, and central nervous system disorders. Its notable products include Simponi for rheumatoid arthritis, multiple diabetes treatments such as Canaglu and Invokana, Radicava for amyotrophic lateral sclerosis, and Gilenya for multiple sclerosis. Additionally, Mitsubishi Tanabe Pharma offers vaccines, including influenza and varicella vaccines, and over-the-counter products. The company collaborates with several organizations to enhance its research and development capabilities. Founded in 1678, it operates as a subsidiary of Mitsubishi Chemical Holdings Corporation.
Mayapada Hospital
Post in 2024
Mayapada Hospital offers health and hospital management services. They provide a range of services ranging from diagnosis, therapy, surgery, and rehabilitation to comprehensive care and control of neurological disorders. They offer clinical services and medical consultations for digestive tract problems. Their paediatric centre also provides physical check-ups, vaccinations, and treatment for specific paediatric symptoms, heart failure, and orthopaedic disorders.
Kestra Medical Technologies
Private Equity Round in 2024
Kestra Medical Technologies, Inc. specializes in the development and manufacturing of wearable medical devices designed for monitoring and managing acute medical conditions. Founded in 2014 and based in Kirkland, Washington, the company offers solutions that collect, communicate, and store patient performance data, enabling both real-time and retrospective analysis. Among its products are wearable cardioverter defibrillators, which aim to prevent sudden cardiac death and facilitate cardiac recovery in at-risk patients. Kestra Medical Technologies focuses on creating intuitive and mobile diagnostic and therapeutic technologies that support healthcare providers and enhance patient care.
Disclo
Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.
Disclo
Pre Seed Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.
Topography Health
Series A in 2022
Topography Health is a clinical trials platform designed to facilitate private practice physicians' participation in medical research. The company aids medical practices in understanding their patient demographics and recommends suitable studies that are likely to be effective and well-received. Additionally, Topography assists in patient recruitment and the hiring and management of research staff. By enabling local clinical trials, Topography Health provides patients with various health conditions access to personalized clinical trial opportunities, ultimately advancing medical research and overcoming barriers that physicians face in entering this field.
InnovaCare Health
Acquisition in 2021
InnovaCare Health Solutions, LLC is a prominent provider of managed healthcare services in North America, focusing on enhancing access to quality and affordable care. Founded in 1998 and headquartered in Fort Lee, New Jersey, the company offers a range of services including managed care, Medicare plans, and physician network services. InnovaCare operates through two primary avenues: Provider Networks and Medicare Advantage, emphasizing sustainable, cost-effective, and technologically integrated healthcare models. The organization is dedicated to fostering strong patient-provider relationships, which it believes are essential for achieving optimal health outcomes and quality of life. By providing integrated health plans and clinical networks, InnovaCare aims to improve the overall healthcare experience for patients, providers, and stakeholders alike, while maintaining a commitment to transparency and quality in healthcare management.
Centivo
Venture Round in 2021
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Nautilus Biotechnology
Post in 2021
Nautilus Biotechnology is a development-stage life sciences company focused on advancing proteomics, the study of proteins and their functions, to enhance therapeutic development and medical diagnostics. The company has created a platform technology that aims to quantify and unravel the complexities of the human proteome. Its flagship product, the Proteomic Analysis System, is a prototype single-molecule instrument designed to facilitate these efforts. The team at Nautilus comprises experts from various disciplines, including protein chemistry, molecular biology, and data science, enabling a multifaceted approach to overcoming challenges in the field. By harnessing this diverse expertise, Nautilus aims to revolutionize drug development and improve healthcare management through personalized and predictive medicine.
ConvenientMD
Private Equity Round in 2021
ConvenientMD LLC is an urgent care provider that offers a wide range of medical services for non-life-threatening injuries and illnesses. Established in 2011 and headquartered in Portsmouth, New Hampshire, the company caters to patients seeking treatment for conditions such as sprains, fractures, cuts, colds, bronchitis, and urinary tract infections. Additionally, ConvenientMD provides preventive care services, including physicals, immunizations, and on-site prescriptions, as well as X-ray and lab services. Patients can access care without appointments from 8 am to 8 pm, seven days a week, with the expectation of being treated within an hour. The organization emphasizes quality care and customer service, employing a fully equipped medical team at its locations across New Hampshire, Maine, and Massachusetts, with plans for further expansion in New England.
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Hazel Health
Series C in 2020
Hazel Health, Inc. is a healthcare company focused on enhancing access to healthcare services for K-12 students. Founded in 2015 and based in San Francisco, the company provides a telehealth platform that allows students to consult with healthcare professionals through live video, whether they are at school or at home. By partnering with schools and school nurses, Hazel Health aims to improve the health and well-being of students, ensuring they remain healthy and prepared to learn. The platform addresses a variety of physical and behavioral health conditions, enabling doctors to prescribe over-the-counter medications at school with parental consent or call in prescriptions as needed. Hazel Health was previously known as HippoMD, Inc. before rebranding in September 2017.
Rapid Micro Biosystems
Venture Round in 2020
Rapid Micro Biosystems is a life sciences technology company that specializes in products designed to detect microbial contamination in the manufacturing processes of pharmaceutical, biotechnology, and personal care products. Its flagship offering, the Growth Direct System, automates and modernizes traditional microbial quality control testing, providing a non-destructive method for microbial enumeration. The company, originally established as Genomic Profiling Systems in 2006, rebranded in 2007 and is headquartered in Lowell, Massachusetts, with an additional office in Germany. In addition to its automated systems, Rapid Micro Biosystems offers a range of services, including on-site installation, regulatory compliance assistance, system certification training, and technical support, serving clients across the Americas and Europe. Their solutions are utilized in various applications such as environmental monitoring, water testing, and bioburden testing, facilitating the efficient manufacturing and release of critical healthcare products.
Affinivax
Series B in 2020
Affinivax, Inc. is a biotechnology company based in Lexington, Massachusetts, focused on developing innovative vaccines using its proprietary Multiple Antigen Presenting System (MAPS) technology. This approach allows for the combination of protective polysaccharides and proteins into a single vaccine, thereby enhancing immune responses against a variety of infectious diseases affecting both children and adults. Affinivax targets several significant pathogens, including Streptococcus pneumoniae, bacterial nosocomial infections, Salmonella typhi, and Staphylococcus aureus. The company aims to create vaccines that not only provide broader disease coverage compared to existing options but also address infectious diseases lacking effective immunization strategies. Founded in 2014, Affinivax benefits from the expertise of leading professionals in infectious diseases and vaccines, and it has received backing from the Bill & Melinda Gates Foundation, along with an exclusive license from Boston Children’s Hospital for its MAPS technology.
Verana Health
Series D in 2020
Verana Health, Inc. is a digital health company based in San Francisco, California, that specializes in transforming healthcare data into actionable insights. Founded in 2008 and formerly known as Digisight Technologies, the company connects healthcare providers with patients through innovative solutions. Its flagship product, SightBook, is a mobile application that enables users to test their vision and share results with their physicians in real-time, facilitating timely appointments and treatments. Verana Health manages data from over 20,000 healthcare providers and 70 electronic health record systems, leveraging its AI-enhanced platform, VeraQ™, to create a robust healthcare data ecosystem. By utilizing advanced analytics on curated datasets, Verana Health supports life sciences partners in improving clinical research and enhancing patient care outcomes.
Zelis
Venture Round in 2020
Zelis is a healthcare and financial technology company that specializes in claims cost management and payments optimization solutions. Founded in 2016 and based in Bedminster, New Jersey, Zelis provides integrated services such as network analytics, payment integrity, electronic payments, and claims communications. These offerings aim to streamline the pricing, payment, and explanation of healthcare claims for payers, healthcare providers, and consumers across medical, dental, and workers' compensation markets. By leveraging advanced technology, Zelis assists its clients in navigating the complexities of the healthcare financial landscape while ensuring compliance with evolving regulations. The company is supported by investment firms Parthenon Capital Partners and Bain Capital.
Kestra Medical Technologies
Private Equity Round in 2020
Kestra Medical Technologies, Inc. specializes in the development and manufacturing of wearable medical devices designed for monitoring and managing acute medical conditions. Founded in 2014 and based in Kirkland, Washington, the company offers solutions that collect, communicate, and store patient performance data, enabling both real-time and retrospective analysis. Among its products are wearable cardioverter defibrillators, which aim to prevent sudden cardiac death and facilitate cardiac recovery in at-risk patients. Kestra Medical Technologies focuses on creating intuitive and mobile diagnostic and therapeutic technologies that support healthcare providers and enhance patient care.
LunaPBC
Venture Round in 2019
LunaPBC, Inc. is a Public Benefit Corporation based in San Diego, California, that develops a community-owned platform for genomic and medical research. The company's primary offering, LunaDNA, serves as a knowledge database where individuals can share their health and DNA data to contribute to health research and drive medical discoveries. This platform is designed to benefit both non-profit and for-profit health research projects, facilitating collaboration among pharmaceutical, insurance, and healthcare IT companies. In addition to advancing medical research, LunaPBC allows its members to share in the financial benefits derived from medical breakthroughs, promoting a model of shared community ownership.
ImageMoverMD
Venture Round in 2019
ImageMoverMD is a medical imaging software company that integrates enterprise imaging and electronic health record systems. The company's innovative solutions employ an exclusive approach to securely connect photos, video, and outside medical images with the EHR, simplifying communication, and enhancing patient care. It transforms enterprise imaging to improve the quality and cost of care while optimizing patient and provider experience. ImagerMoverMD using web-native automation applications that integrate with both the EMR and the VNA/PACs systems, the ImageMover platform measurably improves efficiency, increases revenue capture, and drives HIPAA compliance across the entire care continuum. It also provides end-to-end imaging optimization for health systems.
Centrichealth
Debt Financing in 2018
Centric Health offers an innovative approach to primary healthcare in Ireland, the UK, and Australia, focusing on keeping patients healthy within their communities. The company provides a wide range of accessible medical services that traditionally would have required hospital visits, including community general practice clinics, urgent care facilities, diagnostic imaging centers, and occupational health services. By addressing local healthcare needs proactively, Centric Health aims to enhance patient care and treatment for chronic conditions, ensuring that patients are at the center of their operations.
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Rapid Micro Biosystems
Venture Round in 2018
Rapid Micro Biosystems is a life sciences technology company that specializes in products designed to detect microbial contamination in the manufacturing processes of pharmaceutical, biotechnology, and personal care products. Its flagship offering, the Growth Direct System, automates and modernizes traditional microbial quality control testing, providing a non-destructive method for microbial enumeration. The company, originally established as Genomic Profiling Systems in 2006, rebranded in 2007 and is headquartered in Lowell, Massachusetts, with an additional office in Germany. In addition to its automated systems, Rapid Micro Biosystems offers a range of services, including on-site installation, regulatory compliance assistance, system certification training, and technical support, serving clients across the Americas and Europe. Their solutions are utilized in various applications such as environmental monitoring, water testing, and bioburden testing, facilitating the efficient manufacturing and release of critical healthcare products.
Impact Fitness
Private Equity Round in 2017
Impact Fitness is a leading Planet Fitness franchisee with 29 clubs across the United States and Canada. Here At Impact Fitness, We Believe In Revolutionizing The Fitness Industry. Our Gym Is A Strong, Safe, Exciting And Positive Atmosphere For Everyone. We Offer Only The Most Innovated State Of The Art Equipment, The Biggest Selection Of Free Weights, The Newest In Technology For Cardio Training And The Best In Class Group Exercise Program With An Unparalleled Level Of Commitment To Our Gym Members To Help Them Succeed In Their Fitness Goals. Impact Fitness Is A Gym For Everyone To Come And Achieve The Best They Can From Themselves, No Matter What Your Goal Is. Come See Why Our Local Gym in Auburn Is Making A Difference In How Everyone Achieves Their Fitness Goals Today!
Halo Health
Series A in 2017
Halo Health Inc. provides innovative technology solutions for clinical communication and care coordination in healthcare organizations across the United States. The company has developed a comprehensive clinical communication platform that includes features such as secure messaging, enterprise-wide scheduling, and patient engagement tools. Its offerings, including Halo Messaging, Halo Pronto, Patient Halo, and Halo Handoff, facilitate real-time communication among healthcare providers and streamline patient transitions. The platform enables healthcare professionals to send secure text messages, share critical images, and access essential information such as electronic health records and lab results, all while ensuring HIPAA compliance. By eliminating outdated communication methods like pagers and enhancing care coordination, Halo Health aims to improve response times and reduce patient readmission rates. Founded in 2010 and headquartered in Cincinnati, Ohio, with an additional office in Columbus, Halo Health continues to focus exclusively on transforming patient care through its advanced communication solutions.
Asia Pacific Medical Group
Acquisition in 2016
Asia Pacific Medical Group operates a network of hospitals across Southeast Asia, focusing on both local and international patients. The group provides a comprehensive range of medical services, including neurology, oncology, cardiovascular medicine, pediatrics, dermatology, neurosurgery, plastic surgery, and tumor treatment therapies. Their facilities are designed to deliver inpatient healthcare services while ensuring affordability for patients seeking treatment. By offering specialized services such as gamma-knife treatment and cosmetology, Asia Pacific Medical Group aims to address various healthcare needs and enhance the quality of care available in the region.
Remedy Partners
Series B in 2015
Remedy Partners, Inc. is a health technology company that specializes in developing software solutions and services aimed at organizing and financing healthcare delivery around patient episodes of care. The company provides analytics, technology, and provider networks to facilitate bundled payment programs for various stakeholders, including payers, employers, and at-risk healthcare providers. Its offerings include contracting programs for payers, administrative support for bundled payment contracts, and concierge-level services for patients, enhancing their connection with care teams. Remedy Partners serves a diverse clientele, including government agencies, managed care organizations, self-funded employers, healthcare systems, and physician groups. Founded in 2011 and headquartered in Darien, Connecticut, with additional offices in New York and Shelton, the company delivers its services to healthcare partners nationwide. In 2019, Remedy Partners was acquired by Signify Health, LLC.
MedHOK
Private Equity Round in 2014
MedHOK offers a unified platform designed to enhance Integrated Actionable Healthcare by focusing on Care, Quality, and Compliance. The company aims to improve clinical outcomes and quality measures while ensuring that reimbursement is tied to these enhanced quality outcomes. MedHOK serves a variety of healthcare entities, including health plans, accountable care organizations, patient-centered medical homes, pharmacy benefit managers, and specialty pharmacies, facilitating a more efficient and effective healthcare delivery system. Through its innovative approach, MedHOK addresses the complexities of healthcare management, striving to create better healthcare experiences and outcomes for patients.
National Cardiovascular Partners
Venture Round in 2014
National Cardiovascular Partners specializes in providing endovascular, vascular, and cardiovascular services in outpatient settings. The company operates 21 outpatient vascular centers across six states, collaborating with over 200 physicians. NCP focuses on independent outpatient cardiac catheterization and vascular labs, where physician entrepreneurs serve as majority stakeholders, retaining clinical and financial control of their practices. Meanwhile, NCP manages the administrative and back-office operations, allowing physicians to prioritize high-quality patient care. This model fosters innovative healthcare delivery while ensuring efficient operational support.
Boston Heart Diagnostics
Series C in 2010
Boston Heart Diagnostics is a healthcare company based in Framingham, Massachusetts, specializing in cardiovascular disease (CVD) management. The company offers a comprehensive suite of medical diagnostics services, including advanced lipid testing, genetic testing, and various laboratory techniques such as gas chromatography and liquid chromatography. Unlike traditional lipid testing providers focused on primary screening, Boston Heart utilizes proprietary testing technology to enable ongoing monitoring of patients' conditions and to identify the most effective pharmaceutical treatments more quickly. This approach allows for personalized treatment options for patients with dyslipidemia, determining the efficacy of lipid-adjusting drugs typically within the first six weeks of treatment, in contrast to the six months required by competing methods. Through its innovative tools and patient support services, Boston Heart aims to enhance disease management for physicians, patients, and pharmaceutical companies.
SynapDx is a laboratory testing service provider focused on the early detection of autism spectrum disorders (ASDs) in children. Founded by Stanley Lapidus, the company aims to assist physicians in evaluating developmental disorders through innovative blood-based diagnostic tests and equipment. By collaborating with experts in ASD and gene expression from prominent institutions, SynapDx seeks to enhance the capability of healthcare providers to identify early symptoms of autism. The company is headquartered in Lexington, Massachusetts, and has secured funding from notable investors, including North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners.
Enclarity
Series C in 2009
Enclarity specializes in information management and analytic software services tailored for the healthcare sector. The company maintains the largest and most accurate database of medical providers, which is utilized by major health insurance plans, preferred provider organizations, and medical device manufacturers. Enclarity's offerings include ProviderPoint, a hosted information solution for healthcare providers, and a specialized version for medical device manufacturers that ensures access to correct and current provider information. Other services include Physician Office Attributes, ProviderLookup, a web-based search tool for provider information, and Provider SelectFile, a subscription service delivering timely provider data based on specific needs. By addressing the challenges of provider information accuracy and accessibility, Enclarity enhances claims processing, regulatory compliance, and marketing efforts for its clients.
Enclarity
Series B in 2007
Enclarity specializes in information management and analytic software services tailored for the healthcare sector. The company maintains the largest and most accurate database of medical providers, which is utilized by major health insurance plans, preferred provider organizations, and medical device manufacturers. Enclarity's offerings include ProviderPoint, a hosted information solution for healthcare providers, and a specialized version for medical device manufacturers that ensures access to correct and current provider information. Other services include Physician Office Attributes, ProviderLookup, a web-based search tool for provider information, and Provider SelectFile, a subscription service delivering timely provider data based on specific needs. By addressing the challenges of provider information accuracy and accessibility, Enclarity enhances claims processing, regulatory compliance, and marketing efforts for its clients.
Eyetel Imaging
Series B in 2005
EyeTel Imaging, founded in 1996, specializes in developing imaging technologies aimed at addressing vision loss caused by undetected diabetic retinopathy. The company signed a license agreement with Johns Hopkins University to commercialize new retinal imaging technology, leading to the creation of the EyeTel Retinal Imaging System, which is based on the DigiScope, a semi-automated fundus camera. This system enables the detection of various ocular conditions, including age-related macular degeneration and glaucoma. EyeTel also operates the EyeTel Reading Center, a telemedicine service that offers expert analysis of patient images. Collaborating with the Wilmer Eye Institute, EyeTel has ensured extensive clinical validation of its products. The company has established manufacturing partnerships to produce the DigiScope cost-effectively, and its enhancements have made the system a reliable diagnostic tool for optometrists.
Eyetel Imaging
Series B in 2004
EyeTel Imaging, founded in 1996, specializes in developing imaging technologies aimed at addressing vision loss caused by undetected diabetic retinopathy. The company signed a license agreement with Johns Hopkins University to commercialize new retinal imaging technology, leading to the creation of the EyeTel Retinal Imaging System, which is based on the DigiScope, a semi-automated fundus camera. This system enables the detection of various ocular conditions, including age-related macular degeneration and glaucoma. EyeTel also operates the EyeTel Reading Center, a telemedicine service that offers expert analysis of patient images. Collaborating with the Wilmer Eye Institute, EyeTel has ensured extensive clinical validation of its products. The company has established manufacturing partnerships to produce the DigiScope cost-effectively, and its enhancements have made the system a reliable diagnostic tool for optometrists.
Liberty Dialysis
Seed Round in 2002
Liberty Dialysis, LLC, headquartered in Mercer Island, Washington, specializes in the development, ownership, and operation of dialysis clinics across the United States. Established in 2002, the company serves patients with chronic kidney disease by offering outreach programs and home dialysis options. Liberty Dialysis operates numerous clinics in states including Alaska, California, Colorado, and more, aiming to deliver optimal care through patient education and advanced technology. As of February 2012, Liberty Dialysis is a subsidiary of Fresenius Medical Care AG & Co. KGAA, enhancing its capacity to provide comprehensive renal care.
Definity Health
Venture Round in 2000
Definity Health focuses on the development of programs and products to enhance the consumer health care experience. Definity Health develops solutions that educate patients to assist them to make decision in treatments. Definity Health is acquired by UnitedHealth Group. Definity Health was founded in 1998 and is based in Saint Louis Park, Minnesota.